Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 8, 2015

Varian’s VitalBeam radiotherapy treatment platform gets FDA and CE Mark approval

Varian Medical Systems (VAR) has secured 510(k) clearance from US Food and Drug Administration (FDA) for its VitalBeam platform that was developed to provide advanced radiotherapy.

CMCH

Varian Medical Systems (VAR) has secured 510(k) clearance from US Food and Drug Administration (FDA) for its VitalBeam platform that was developed to provide advanced radiotherapy.

The company also received CE Mark approval for the VitalBeam platform, which was first acquired by Chirayu Medical College and Hospital (CMCH) in Bhopal, India.

Apart from the CMCH in India, treatment centres in the US and Europe have ordered the VitalBeam platform.

CMCH owner Dr Ajay Goenka said: "We are looking to increase the capacity in our region for helping cancer patients with the most advanced treatments possible, and we are making efforts to provide patients with the best available treatments in the world.

"We chose VitalBeam because we wanted something with the advantages of the TrueBeam platform that would enable us to go beyond basic intensity modulated radiotherapy."

"We chose VitalBeam because we wanted something with the advantages of the TrueBeam platform that would enable us to go beyond basic intensity modulated radiotherapy."

The VitalBeam platform is said to integrate Varian’s multiple innovations to improve the precision, safety and speed of treatment on its TrueBeam radiotherapy system.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

CMCH physician Dr TP Sahoo said: "The VitalBeam system will enable us to complete image-guided treatments quickly, in as little as two to four minutes when using advanced capabilities like RapidArc, and to shape the radiation dose very precisely."

Dr Sahoo noted the clinical team at the hospital will use the VitalBeam system to treat patients with tumours in vital locations where toxicity to healthy tissues must be minimised.

Varian Oncology Systems business president Kolleen Kennedy said: "Our goal, with this platform, was to help increase access to quality cancer care around the world.

"We are gratified to work with institutions like the Chirayu Medical College in bringing advanced, image-guided radiotherapy to more cancer patients."

Varian offers comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy, as well as informatics software for managing comprehensive cancer clinics, radiotherapy centres and medical oncology practices.

The company also supplies x-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.


Image: The VitalBeam radiotherapy treatment platform from Varian Medical Systems. Photo: courtesy of Varian Medical Systems / PRNewswire.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU